Gene · 2813
NIH grants1,628
NIH grants whose papers are about the gene, through NIH's grant-paper links.
461 to 480 of 1,628
Download this page as JSON| Grant | Title | GP2 papers | Newest fiscal year |
|---|---|---|---|
| R01DK122160 | Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes | 1 | 2022 |
| R01EB028320 | Programmable Synthetic Organelles Built from Disordered Proteins for Cellular Engineering | 1 | 2022 |
| R01GM076661 | Understanding the Protein: Protein Interactions Required for Virus Assembly | 1 | 2022 |
| R01GM127802 | Elucidating mechanisms of microRNA pathway deregulation in human cells | 1 | 2022 |
| R01HD095880 | Development of a mucosal, polyanhydride-based nanoparticle vaccine for use against RSV infection in the neonate | 1 | 2022 |
| R01HL094505 | ER-to-Golgi transport of coagulation factors V and VIII | 1 | 2022 |
| R01MH081923 | Single Molecule Analysis of MAGUK Structure and Ligand Binding | 1 | 2022 |
| R01MH117406 | The Spatiotemporal Landscape of the Human Brain Epitranscriptome | 1 | 2022 |
| R21ES032432 | Particulate Matter-Induced Pulmonary Exosomes and the Lung-Brain Axis | 1 | 2022 |
| R21LM013678 | COVID-19 disease course analysis using multi-site large-scale EHR data | 1 | 2022 |
| R35GM128748 | Regulation of the Timing and Spatial Patterning of Zygotic Genome Activation During Embryogenesis | 1 | 2022 |
| S10OD030457 | A New Cryo-Transmission Electron Microscope at Thomas Jefferson University | 1 | 2022 |
| T32GM008111 | Training Program in Cell, Molecular, and Developmental Biology | 1 | 2022 |
| T32HL007824 | Training Program in Molecular and Cellular Cardiology | 1 | 2022 |
| U01AI136779 | Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients | 1 | 2022 |
| U01AI138329 | Endothelial cell transplantation for multi-organ repair to counter radiation injury | 1 | 2022 |
| U01CA214297 | Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation | 1 | 2022 |
| U01CA233100 | Molecular and immune drivers of immunotherapy responsiveness in prostate cancer | 1 | 2022 |
| U01CA244452 | Mechanisms of Exosome Driven Immunoregulation of Cancer Progression | 1 | 2022 |
| U01HG007690 | Center for Integrated Approached to Undiagnosed Diseases | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2813/grants?page=24